Page 19 - Read Online
P. 19

Verolino et al. Vessel Plus 2018;2:17  I  http://dx.doi.org/10.20517/2574-1209.2018.32                                                Page 11 of 12

                   Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL,
                   Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC,
                   Webb JG; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med
                   2016;374:1609-20.
               29.  Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chet-
                   cuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R,
                   Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Surgical or transcath-
                   eter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321-31.
               30.  Thyregod HG, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrøm T, Clemmensen P,
                   Hansen PB, Andersen LW, Olsen PS, Søndergaard L. Transcatheter versus surgical aortic valve replacement in patients with severe aor-
                   tic valve stenosis: 1-year results from the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 2015;65:2184-94.
               31.  Thyregod HG. Five-year outcomes from the All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial in patients with
                   severe aortic valve stenosis. ACC Annual Congress; 2018.
               32.  Wenaweser P, Stortecky S, Schwander S, Heg D, Huber C, Pilgrim T, Gloekler S, O’Sullivan CJ, Meier B, Juni P, Carrel T, Windecker
                   S. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur
                   Heart J 2013;34:1894-905.
               33.  Tamburino C,Barbanti M, D’Errigo P, Ranucci M, Onorati P, Covello RD, Santini F, Rosato S, Santoro G, Fusco D, Grossi C, Secca-
                   reccia F; OBSERVANT Research Group. 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results
                   from the Italian OBSERVANT Study. J Am Coll Cardiol 2015;66:804-12.
               34.  Tarantini G, Nai Fovino L, Gers BJ. Transcatheter aortic valve implantation in lower-risk patients: what is the perspective? Eur Heart J
                   2018;39:1-12.
               35.  Thourani VH, Forcillo J, Szeto WY, Kodali SK, Blackstone EH, Lowry AM, Semple M, Rajeswaran J, Makkar RR, Williams MR, Ba-
                   varia JE, Herrmann HC, Maniar HS, Babaliaros VC, Smith CR, Trento A, Corso PJ, Pichard AD, Craig Miller D, Svensson LG, Kapa-
                   dia S, Ailawadi G, Suri RM, Greason KL, Hahn RT, Jaber WA, Alu MC, Leon MB, Mack MJ; PARTNER Trial Investigators. Outcomes
                   in 937 intermediate-risk patients undergoing surgical aortic valve replacement in PARTNER-2A. Ann Thorac Surg 2018;105:1322-9.
               36.  Garcia S, Kelly R, Mbai M, Gurevich S, Oestreich B, Yannopoulos D, Adabag S. Outcomes of intermediate-risk patients treated with
                   transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: a single center 20-year experience. Cath-
                   eter Cardiovasc Interv 2018; doi: 10.1002/ccd.27478.
               37.  Tarantini G, Gasparetto V, Napodano M, Fraccaro C, Gerosa G, Isabella G. Valvular leak after transcatheter aortic valve implantation: a
                   clinician update on epidemiology, pathophysiology and clinical implications. Am J Cardiovasc Dis 2011;1:312-20.
               38.  Bauer T, Linke A, Sievert H, Kahlert P, Hambrecht R, Nickenig G, Hauptmann KE, Sack S, Gerckens U, Schneider S, Zeymer U, Zahn
                   R. Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic
                   valves (from the German TAVI Registry). Am J Cardiol 2014;113:518-21.
               39.  Phan K, Wong S, Phan S, Ha H, Qian P, Yan TD. Transcatheter aortic valve implantation (aortic valve implantation) in patients with bi-
                   cuspid aortic valve stenosis--systematic review and meta-analysis. Heart Lung Circ 2015;24:649-59.
               40.  Sannino A, Cedars A, Stoler RC, Szerlip M, Mack MJ, Grayburn PA. Comparison of efficacy and safety of transcatheter aortic valve
                   implantation in patients with bicuspid versus tricuspid aortic valves. Am J Cardiol 2017;120:1601-6.
               41.  Praz F, Windecker S, Huber C, Carrel T, Wenaweser P. Expanding indications of transcatheter heart valve interventions. J Am Coll Car-
                   diol Intv 2015;8:1777-96.
               42.  Yoon SH, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, Yzeiraj E, Amat-Santos IJ, Tchetche D, Jung C, Fujita B,
                   Mangieri A, Deutsch MA, Ubben T, Deuschl F, Kuwata S, De Biase C, Williams T, Dhoble A, Kim WK, Ferrari E, Barbanti M, Vollema
                   EM, Miceli A, Giannini C, Attizzani GF, Kong WKF, Gutierrez-Ibanes E, Jimenez Diaz VA, Wijeysundera HC, Kaneko H, Chakravarty T,
                   Makar M, Sievert H, Hengstenberg C, Prendergast BD, Vincent F, Abdel-Wahab M, Nombela-Franco L, Silaschi M, Tarantini G, Butter C,
                   Ensminger SM, Hildick-Smith D, Petronio AS, Yin WH, De Marco F, Testa L, Van Mieghem NM, Whisenant BK, Kuck KH, Colombo A,
                   Kar S, Moris C, Delgado V, Maisano F, Nietlispach F, Mack MJ, Schofer J, Schaefer U, Bax JJ, Frerker C, Latib A, Makkar RR. Trans-
                   catheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol 2017;70:2752-63.
               43.  Franzone A, Piccolo R, Siontis GC, Lanz J, Stortecky S, Praz F, Roost E, Vollenbroich R, Windecker S, Pilgrim T. Transcatheter aortic
                   valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review. JACC Cardiovasc Interv 2016;9:2308-
                   17.
               44.  Sawaya FJ, Deutsch MA, Seiffert M, Yoon SH, Codner P, Wickramarachchi U, Latib A, Petronio AS, Rodés-Cabau J, Taramasso M,
                   Spaziano M, Bosmans J, Biasco L, Mylotte D, Savontaus M, Gheeraert P, Chan J, Jørgensen TH, Sievert H, Mocetti M, Lefèvre T, Mai-
                   sano F, Mangieri A, Hildick-Smith D, Kornowski R, Makkar R, Bleiziffer S, Søndergaard L, De Backer O. Safety and efficacy of trans-
                   catheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results
                   from an International Registry Study. JACC Cardiovasc Interv 2017;10:1048-56.
               45.  Brown JM, O’Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising
                   108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Tho-
                   rac Cardiovasc Surg 2009;137:82-90.
               46.  Ussia GP, Barbanti M, Petronio AS, Tarantini G, Ettori F, Colombo A, Violini R, Ramondo A, Santoro G, Klugmann S, Bedogni F, Mai-
                   sano F, Marzocchi A, Poli A, De Carlo M, Napodano M, Fiorina C, De Marco F, Antoniucci D, de Cillis E, Capodanno D, Tamburino C.
                   Transcatheter aortic valve implantation: 3-year outcomes of selfexpanding CoreValve prosthesis. Eur Heart J 2012;33:969-76.
   14   15   16   17   18   19   20   21   22   23   24